Toxicity of Checkpoint Inhibition in Advanced RCC: A Systematic Review

BACKGROUND: Checkpoint inhibitors (CPI) have now been established as standard agents in the management of patients with metastatic renal cell carcinoma (mRCC). Given the unique toxicity profiles of CPIs, a detailed understanding of their incidence rate and characteristics is critical. OBJECTIVE: To...

Descripción completa

Detalles Bibliográficos
Autores principales: Ornstein, Moshe C., Garcia, Jorge A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2017
Materias:
Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6179114/
https://www.ncbi.nlm.nih.gov/pubmed/30334015
http://dx.doi.org/10.3233/KCA-170017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6179114/
https://www.ncbi.nlm.nih.gov/pubmed/30334015
http://dx.doi.org/10.3233/KCA-170017

Ejemplares similares